Skip to main content
. 2019 Feb 19;14(2):e0212259. doi: 10.1371/journal.pone.0212259

Fig 2. Observation period and defined risk periods for an individual person receiving oral glucocorticoid treatment who stops treatment before end of follow up.

Fig 2